Analyze the latest discoveries in genetics and epigenomics in GU cancer, including diagnosis, minimal residual disease (MRD), monitoring for recurrence, and assessment of therapeutic success with targeted therapy and immunotherapy.

Identify the latest drug developments in GU oncology by an expert panel of senior investigators and KOLs in the field.

Distinguish the importance of GU cancer screening and successful implementation, including programs not only based on imaging but also on liquid biopsies and other technologies.

Understand the multidisciplinary application of new developments in GU cancer to the current standards of care.

Evaluate information on new products and developments in GU cancer care for best utilization.